CSPC Pharmaceutical Group Limited
CHJTF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.66B
Close$
$0.48
56.9% downside
Current Fair Value
56.9% downsideOvervalued by 56.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.66 Billion |
|---|---|
| Enterprise Value | $3.94 Billion |
| Annual dividend | $0.04 |
| Dividend yield | 3.95% |
| Earnings per Share | $0.33 |
| Beta | 0.73 |
| Outstanding Shares | 11,401,166,000 |
Return
| Return on Equity | 25.03% |
|---|---|
| Return on Assets | 16.81% |
| Return on Invested Capital | 31.94% |
Valuation & Multiples
| P/E Ratio | 10.9 |
|---|---|
| PEG | 0.67 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 0.3 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$0.04
Consensus analyst estimateRevenue Estimate
$1.97 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$7.66 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CSPC Pharmaceutical Group Limited.
18,626 employees
CEO: Lei Cai
CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's ...